{
    "organizations": [],
    "uuid": "88b28ded469c7826544f4d415a1eed774c985b89",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-cipla-gets-us-fda-nod-for-g/brief-indias-cipla-gets-u-s-fda-nod-for-generic-viread-tablets-idUSFWN1PN017",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Cipla Gets U.S. FDA Nod For Generic Viread Tablets",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 29 (Reuters) - Cipla Ltd:\n* GETS FINAL APPROVAL FOR GENERIC VIREAD TABLETS * GETS ANDA FOR TENOFOVIR DISOPROXIL FUMARATE TABLETS FROM U.S. FDA Source text - bit.ly/2DW6lbS Further company coverage:\n ",
    "published": "2018-01-29T11:16:00.000+02:00",
    "crawled": "2018-01-29T21:58:33.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "cipla",
        "ltd",
        "get",
        "final",
        "approval",
        "generic",
        "viread",
        "tablet",
        "get",
        "anda",
        "tenofovir",
        "disoproxil",
        "fumarate",
        "tablet",
        "fda",
        "source",
        "text",
        "company",
        "coverage"
    ]
}